Interleukin-12 Levels in Patients with Obstructive Jaundice
Author Information
Author(s): W.G. Jiang, M.C.A. Puntis
Primary Institution: University Department of Surgery, University of Wales College of Medicine
Hypothesis
Patients with obstructive jaundice have increased interleukin-12 levels due to immune dysfunction.
Conclusion
Monocytes in jaundiced patients have a significantly increased capacity to release interleukin-12, which may contribute to immune dysfunction.
Supporting Evidence
- Monocyte IL-12 production was significantly higher in jaundiced patients compared to controls.
- There was no difference in plasma IL-12 levels between jaundiced patients and controls.
- IL-12 may play a role in the immune dysfunction observed in jaundiced patients.
Takeaway
People with a condition called obstructive jaundice have more of a substance called interleukin-12 in their blood, which might affect their immune system.
Methodology
The study measured interleukin-12 levels in monocytes from 23 jaundiced patients and 17 controls using ELISA.
Limitations
The study does not clarify the exact pathway by which monocytes increase IL-12 production.
Participant Demographics
23 jaundiced patients (14 male, 9 female, median age 71) and 17 controls (10 male, 7 female, median age 64).
Statistical Information
P-Value
p<0.01
Statistical Significance
p<0.01
Want to read the original?
Access the complete publication on the publisher's website